Clinical trial Recruiting at 1 site Interventional Ages 18 and up

One session of high-frequency rTMS to help with severe arm weakness after stroke

Official title: Effects of a Single Session of High-Frequency Repetitive Transcranial Magnetic Stimulation on Cortical Mapping of the Upper Limb in Stroke Patients With Severe Upper Limb Impairment

Run by Fundació Sant Joan de Déu · NCT07787793 · Data updated 2026-11-12

This study tests whether a single high-frequency rTMS session on the affected arm can reveal more motor signals in the brain of stroke patients who have little or no hand movement.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment54 (estimated)
SponsorFundació Sant Joan de Déu
Academic / other
Locations1 site (Palma, Balearic Islands)
StatusRecruiting
StartedSeptember 15, 2026
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedAugust 26, 2026
Trial IDNCT07787793 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a first-ever stroke lasting more than 6 months who cannot voluntarily activate hand muscles (finger extension score of 1 or less).

Probably not a fit

Patients with extensive corticospinal damage or contraindications to TMS may not benefit from this single-session intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study uses navigated TMS to map cortical motor activity before and after a single session of 10 Hz rTMS (600 pulses) delivered to the affected motor cortex, compared with sham stimulation, in stroke patients with severe upper limb impairment. The primary aim is to see if the rTMS session increases the number of motor-evoked potential positive points in the cortical map. Participants undergo a cortical motor mapping assessment, receive either real or sham stimulation, and then have a post-intervention mapping to detect any changes. The study addresses the gap in evidence for rTMS effectiveness in patients who are ME- P negative and have minimal voluntary hand function, considering mechanisms like diaschisis and latent corticospinal activity.

Why it matters

Potential benefit: If successful, patients could have improved cortical responsiveness that may support future rehabilitation options.

How similar studies have gone: Prior rTMS studies suggest increased cortical excitability in some patients, but evidence in ME- P individuals is limited and this approach is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* First-ever stroke confirmed by MRI or CT scan.
* Inability to voluntarily activate the hand musculature:

manual muscle testing score of 1 or less in finger extension.

* Time since stroke onset greater than 6 months.

Exclusion Criteria:

* History of craniotomy or metallic implants in the skull.
* Diagnosis of uncontrolled epilepsy.
* Diagnosis of other neurological diseases (dementia, Parkinson's disease, neuropathies, multiple sclerosis, or similar conditions).
* Low level of consciousness or significant cognitive impairment that prevents informed consent or study collaboration.
* Diagnosis of rheumatic disease or presence of hand deformities.
* Pregnancy.

Where it's running

  • Hospital Sant Joan de Déu Palma
    Palma, Balearic Islands, Spain
    Recruiting

Study contacts

  • Principal investigator: Ancor Rebassa Cabrera, PT, MSc — Hospital Sant Joan de Deu
  • Study coordinator: Ancor Rebassa Cabrera, PT, MSc
  • Email: ancor.rebassa@sjd.es
  • Phone: +34 607832655

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.